Surgical Management of Retroperitoneal Sarcoma

被引:6
|
作者
Dominguez, Dana A. A. [1 ]
Sampath, Sagus [2 ]
Agulnik, Mark [3 ]
Liang, Yu [4 ]
Nguyen, Bao [5 ]
Trisal, Vijay [1 ]
Melstrom, Laleh G. G. [1 ]
Lewis, Aaron G. G. [1 ]
Paz, Isaac Benjamin [1 ]
Roberts, Randall F. F. [6 ]
Tseng, William W. W. [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Surg, Div Surg Oncol, 1500 East Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Radiat Oncol, 1500 East Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, 1500 East Duarte Rd, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Dept Pathol, 1500 East Duarte Rd, Duarte, CA 91010 USA
[5] City Hope Natl Med Ctr, Dept Diagnost Radiol, 1500 East Duarte Rd, Duarte, CA 91010 USA
[6] City Hope Natl Med Ctr, Div Thorac Surg, Vasc Surg Sect, 1500 East Duarte Rd, Duarte, CA 91010 USA
关键词
retroperitoneal sarcoma; liposarcoma; leiomyosarcoma; multidisciplinary; collaboration; SOFT-TISSUE SARCOMA; NEOADJUVANT CHEMOTHERAPY; OPEN-LABEL; RESECTION; RECURRENT; SURGERY; MULTICENTER; LIPOSARCOMA; HISTOLOGY; PATTERNS;
D O I
10.3390/curroncol30050349
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Surgery is the cornerstone of treatment for retroperitoneal sarcoma (RPS). Surgery should be performed by a surgical oncologist with sub-specialization in this disease and in the context of a multidisciplinary team of sarcoma specialists. For primary RPS, the goal of surgery is to achieve the complete en bloc resection of the tumor along with involved organs and structures to maximize the clearance of the disease. The extent of resection also needs to consider the risk of complications. Unfortunately, the overarching challenge in primary RPS treatment is that even with optimal surgery, tumor recurrence occurs frequently. The pattern of recurrence after surgery (e.g., local versus distant) is strongly associated with the specific histologic type of RPS. Radiation and systemic therapy may improve outcomes in RPS and there is emerging data studying the benefit of non-surgical treatments in primary disease. Topics in need of further investigation include criteria for unresectability and management of locally recurrent disease. Moving forward, global collaboration among RPS specialists will be key for continuing to advance our understanding of this disease and find more effective treatments.
引用
收藏
页码:4618 / 4631
页数:14
相关论文
共 50 条
  • [31] Personalizing surgical margins in retroperitoneal sarcomas
    Callegaro, Dario
    Fiore, Marco
    Gronchi, Alessandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) : 553 - 567
  • [32] Radiation therapy in retroperitoneal sarcoma management
    Haas, Rick L.
    Baldini, Elizabeth H.
    Chung, Peter W.
    van Coevorden, Frits
    DeLaney, Thomas F.
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (01) : 93 - 98
  • [33] Surgical Principles of Primary Retroperitoneal Sarcoma in the Era of Personalized Treatment: A Review of the Frontline Extended Surgery
    Munoz, Paula
    Bretcha-Boix, Pedro
    Artigas, Vicente
    Manuel Asencio, Jose
    CANCERS, 2022, 14 (17)
  • [34] Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis
    Judge, Sean J.
    Lata-Arias, Kathleen
    Yanagisawa, Mio
    Darrow, Morgan A.
    Monjazeb, Arta M.
    Kirane, Amanda R.
    Bold, Richard J.
    Canter, Robert J.
    Canter, Daniel J.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (04) : 753 - 760
  • [35] Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre
    Snow, Hayden A.
    Hitchen, Tatiana X.
    Head, Jessica
    Herschtal, Alan
    Bae, Susie
    Chander, Sarat
    Chu, Julie
    Hendry, Shona
    Ngan, Samuel Y.
    Desai, Jayesh
    Choong, Peter F. M.
    Henderson, Michael
    Gyorki, David E.
    ANZ JOURNAL OF SURGERY, 2018, 88 (11) : 1151 - 1157
  • [36] Management of retroperitoneal sarcoma involving the iliac artery: Single-center surgical experience
    Li, Wen-Xiang
    Tong, Han-Xing
    Lv, Chen-Tao
    Yang, Hua
    Zhao, Gang
    Lu, Wei-Qi
    Zhang, Yong
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (03) : 811 - 819
  • [37] Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi - institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
    Tseng, William W.
    Barretta, Francesco
    Conti, Lorenzo
    Grignani, Giovanni
    Tolomeo, Francesco
    Albertsmeier, Markus
    Angele, Martin K.
    Rutkowski, Piotr
    Skoczylas, Jacek
    De Paoli, Antonino
    Navarria, Federico
    Raut, Chandrajit P.
    Fairweather, Mark
    Farma, Jeffrey M.
    Nessim, Carolyn
    Goel, Neha
    Grignol, Valerie P.
    Ford, Samuel J.
    Cardona, Kenneth
    Subhawong, Ty
    Tattersall, Hannah L.
    Lee, Rachel M.
    Hu, James S.
    von Mehren, Margaret
    Sanfilippo, Roberta
    Gronchi, Alessandro
    CANCER, 2021, 127 (05) : 729 - 738
  • [38] Major vascular resections in retroperitoneal sarcoma
    Tzanis, Dimitri
    Bouhadiba, Toufik
    Gaignard, Elodie
    Bonvalot, Sylvie
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (01) : 42 - 47
  • [39] Outcome following resection of retroperitoneal sarcoma
    Smith, H. G.
    Panchalingam, D.
    Hannay, J. A. F.
    Smith, M. J. F.
    Thomas, J. M.
    Hayes, A. J.
    Strauss, D. C.
    BRITISH JOURNAL OF SURGERY, 2015, 102 (13) : 1698 - 1709
  • [40] Surgical role, prognostic factors, and outcome prediction in primary retroperitoneal sarcoma: a prospective large cohort study
    Baiomy, Taha A.
    El Fattah, Ahmed R. A.
    Obaya, Ahmed A.
    Ahmed, Rham Z.
    Harb, Ola A.
    Embaby, Ahmed
    El Deen, Dalia S.
    Osman, Gamal
    Ibrahim, Amr
    EGYPTIAN JOURNAL OF SURGERY, 2021, 40 (02) : 566 - 576